tiprankstipranks
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
TVRD
Tvardi Therapeutics
RESEARCH TOOLSreports
Want to see TVRD full AI Analyst Report?

Tvardi Therapeutics (TVRD) Income Statement

2,522 Followers

Tvardi Therapeutics Income Statement

Last quarter (Q4 2025), Tvardi Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tvardi Therapeutics's net income was $-7.28M. See Tvardi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 7.14M$ 20.97M$ 41.87M$ 23.03M
Gross Profit
$ 0.00$ 6.33M$ 14.54M$ 34.35M$ 21.47M
Operating Expenses
$ 26.75M$ 62.11M$ 136.03M$ 121.89M$ 110.56M
Depreciation and Amortization
$ 95.00K$ 192.00K$ 259.00K$ 1.67M$ 1.55M
EBITDA
$ -26.65M$ -62.60M$ -117.65M$ -83.80M$ -86.89M
Operating Income
$ -26.75M$ -55.78M$ -121.50M$ -87.53M$ -89.08M
Other Income/Expenses
$ 8.53M$ -15.48M$ 2.98M$ 2.06M$ 642.00K
Pretax Income
$ -18.21M$ -71.27M$ -118.51M$ -85.47M$ -88.44M
Net Income
$ -18.21M$ -70.87M$ -118.51M$ -85.47M$ -88.44M
Per Share Metrics
Basic EPS
$ -2.46$ -46.59$ -1.85$ -2.20$ -62.77
Diluted EPS
$ -3.26$ -46.59$ -1.85$ -2.20$ -62.77
Weighted Average Shares Outstanding
 7.42M 1.52M 9.36M 9.36M 1.41M
Weighted Average Shares Outstanding (Diluted)
 7.78M 1.52M 9.36M 9.36M 1.41M
Currency in USD

Tvardi Therapeutics Earnings and Revenue History